US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLIMB BIO INC

17.84

+1.448.78%

Pre-market: 17.850.0100+0.06%04:09 EDT

Volume:1.20M

Turnover:21.45M

Market Cap:1.02B

PE:-21.37

High:18.33

Open:16.75

Low:16.75

Close:16.40

52wk High:18.33

52wk Low:1.54

Shares:57.26M

Float Shares:41.60M

Volume Ratio:1.10

T/O Rate:2.89%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8347

EPS(LYR):-0.8974

ROE:-27.10%

ROA:-18.45%

PB:4.26

PE(LYR):-19.88

Loading ...

Overview Company News Filings

Climb Bio Initiated at Buy by Chardan Capital

Climb Bio reports Phase 1 budoprutug subcutaneous data supports patient trials

Chardan Initiates Climb Bio at Buy With $22 Price Target

MT Newswires Live

U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi

Climb Bio Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $22

THOMSON REUTERS

Analysts Have Conflicting Sentiments on These Healthcare Companies: Climb Bio (CLYM), ICU Medical (ICUI) and Stryker (SYK)

Piper Sandler Remains a Buy on Climb Bio (CLYM)

BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics

Climb Bio prices USD 110 million private placement at USD 9.5 per share

Climb Bio Inc - Private Placement Expected to Close on or About April 29, 2026

THOMSON REUTERS

Press Release: Climb Bio, Inc. Announces $110.0 Million Private Placement

Climb Bio announces annual shareholder meeting

Analysts Offer Insights on Healthcare Companies: Passage Bio (PASG), Climb Bio (CLYM) and Zai Lab (ZLAB)

U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis

Climb Bio Inc : Mizuho Initiates Coverage With Outperform Rating; Price Target $18

THOMSON REUTERS

Climb Bio announces annual shareholder meeting

Climb Bio (CLYM) Gets a Buy from Piper Sandler

Climb Bio hosts R&D Spotlight webcast on budoprutug CD19 program opportunity

Climb Bio Price Target Maintained With a $8.00/Share by BTIG

Climb Bio says FDA grants Fast Track designation for budoprutug in pMN

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/CLYM/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CLYM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","market":"US","secType":"STK","nameCN":"CLIMB BIO INC","latestPrice":17.84,"timestamp":1787688000000,"preClose":16.4,"halted":0,"volume":1204167,"hourTrading":{"tag":"盘前","latestPrice":17.85,"preClose":17.84,"latestTime":"04:09 EDT","volume":3,"amount":53.400000000000006,"timestamp":1787731777062,"change":0.01,"changeRate":0.000561,"amplitude":0.005605},"delay":0,"changeRate":0.08780487804878058,"floatShares":41603800,"shares":57260500,"eps":-0.83475,"marketStatus":"Pre-Mkt","change":1.44,"latestTime":"08-26 04:58:30 EDT","open":16.75,"high":18.33,"low":16.75,"amount":21448907.991579,"amplitude":0.096341,"askPrice":19.48,"askSize":100,"bidPrice":7.14,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.83475,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":17.84,"preHourTrading":{"tag":"盘前","latestPrice":17.85,"preClose":17.84,"latestTime":"04:09 EDT","volume":3,"amount":53.400000000000006,"timestamp":1787731777062,"change":0.01,"changeRate":0.000561,"amplitude":0.005605},"postHourTrading":{"tag":"盘后","latestPrice":17.21,"preClose":17.84,"latestTime":"19:30 EDT","volume":64561,"amount":1149364.8915,"timestamp":1787700602724,"change":-0.63,"changeRate":-0.035314,"amplitude":0.036441},"volumeRatio":1.0975599086250922,"impliedVol":1.5488,"impliedVolPercentile":0.6846},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","floatShares":41603800,"roa":"-18.45%","roe":"-27.10%","lyrEps":-0.897422,"volumeRatio":1.0975599086250922,"shares":57260500,"dividePrice":0,"high":18.33,"amplitude":0.096341,"preClose":16.4,"low":16.75,"week52Low":1.54,"pbRate":"4.26","week52High":18.33,"institutionHeld":0,"latestPrice":17.84,"committee":0.333333,"eps":-0.83475,"divideRate":0,"volume":1204167,"delay":0,"ttmEps":-0.83475,"open":16.75,"prevYearClose":4,"prevWeekClose":17.28,"prevMonthClose":11.9,"prevQuarterClose":13.04,"fiveDayClose":17.39,"twentyDayClose":12.29,"sixtyDayClose":10.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLYM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"CLYM","fiscalQuarterEnding":"2026/06","expectedEps":-0.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2026-05-07","symbol":"CLYM","fiscalQuarterEnding":"2026/03","expectedEps":-0.26,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2026-03-05","symbol":"CLYM","fiscalQuarterEnding":"2025/12","expectedEps":-0.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-11-06","symbol":"CLYM","fiscalQuarterEnding":"2025/09","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2025-08-12","symbol":"CLYM","fiscalQuarterEnding":"2025/06","expectedEps":-0.19,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLYM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLYM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5333,"buy":0.4667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5333,"analysts":15,"updateTime":1785816000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLYM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLYM","date":"2026-08-25","current":-21.371668,"percent":0.010638,"low":-17.383179,"twenty":-6.726423,"median":-3.063494,"eighty":-1.241817,"high":-0.85032,"avg":-4.567303,"sd":4.034324,"marketCap":941954582},"quantilePoints":[{"date":"2024-10-04","current":-5.327624,"twenty":-5.327624,"median":-5.327624,"eighty":-5.327624,"marketCap":342006831},{"date":"2024-10-11","current":-5.369409,"twenty":-5.463426,"median":-5.390302,"eighty":-5.369409,"marketCap":344689237},{"date":"2024-10-18","current":-5.076912,"twenty":-5.494765,"median":-5.390302,"eighty":-5.327624,"marketCap":325912392},{"date":"2024-10-25","current":-4.85754,"twenty":-5.463426,"median":-5.327624,"eighty":-5.014234,"marketCap":311829757},{"date":"2024-10-31","current":-4.094958,"twenty":-5.404927,"median":-5.238831,"eighty":-4.776059,"marketCap":262875838},{"date":"2024-11-08","current":-3.677105,"twenty":-5.390302,"median":-5.014234,"eighty":-4.074065,"marketCap":236051773},{"date":"2024-11-15","current":-3.107258,"twenty":-5.373588,"median":-4.888879,"eighty":-3.806639,"marketCap":214779913},{"date":"2024-11-22","current":-2.917613,"twenty":-5.335981,"median":-4.293438,"eighty":-3.619939,"marketCap":201671280},{"date":"2024-11-29","current":-3.141297,"twenty":-5.327624,"median":-4.220314,"eighty":-3.127681,"marketCap":217132744},{"date":"2024-12-06","current":-2.830085,"twenty":-5.277482,"median":-3.974826,"eighty":-3.040153,"marketCap":195621141},{"date":"2024-12-13","current":-2.742557,"twenty":-5.237786,"median":-3.781569,"eighty":-2.995417,"marketCap":189571003},{"date":"2024-12-20","current":-1.896449,"twenty":-5.13959,"median":-3.671882,"eighty":-2.96235,"marketCap":131086332},{"date":"2024-12-27","current":-2.207661,"twenty":-5.051841,"median":-3.301766,"eighty":-2.921503,"marketCap":152597935},{"date":"2025-01-03","current":-2.013153,"twenty":-5.003788,"median":-3.151022,"eighty":-2.57139,"marketCap":139153183},{"date":"2025-01-10","current":-1.818646,"twenty":-4.962003,"median":-3.124277,"eighty":-2.236837,"marketCap":125708431},{"date":"2025-01-17","current":-1.954801,"twenty":-4.920218,"median":-3.063494,"eighty":-2.032604,"marketCap":135119757},{"date":"2025-01-24","current":-1.770019,"twenty":-4.870076,"median":-3.005142,"eighty":-1.952856,"marketCap":122347243},{"date":"2025-01-31","current":-1.876998,"twenty":-4.531614,"median":-2.995417,"eighty":-1.91979,"marketCap":129741856},{"date":"2025-02-07","current":-1.701941,"twenty":-4.324777,"median":-2.96624,"eighty":-1.892559,"marketCap":117641580},{"date":"2025-02-14","current":-1.546335,"twenty":-4.251653,"median":-2.932201,"eighty":-1.865328,"marketCap":106885778},{"date":"2025-02-21","current":-1.400454,"twenty":-4.228671,"median":-2.873849,"eighty":-1.840042,"marketCap":96802214},{"date":"2025-02-28","current":-1.351828,"twenty":-4.1451,"median":-2.528598,"eighty":-1.818646,"marketCap":93441026},{"date":"2025-03-07","current":-1.429631,"twenty":-4.03228,"median":-2.256288,"eighty":-1.756403,"marketCap":98818927},{"date":"2025-03-14","current":-1.293475,"twenty":-3.971692,"median":-2.18821,"eighty":-1.542445,"marketCap":89407600},{"date":"2025-03-21","current":-1.244848,"twenty":-3.871407,"median":-2.022879,"eighty":-1.474368,"marketCap":86046412},{"date":"2025-03-28","current":-1.159638,"twenty":-3.794104,"median":-1.954801,"eighty":-1.429631,"marketCap":85693751},{"date":"2025-04-04","current":-1.050066,"twenty":-3.724618,"median":-1.940213,"eighty":-1.381004,"marketCap":77596704},{"date":"2025-04-11","current":-1.059197,"twenty":-3.680923,"median":-1.925625,"eighty":-1.357663,"marketCap":78271458},{"date":"2025-04-17","current":-1.150507,"twenty":-3.672927,"median":-1.896449,"eighty":-1.324596,"marketCap":85018997},{"date":"2025-04-25","current":-1.187031,"twenty":-3.573219,"median":-1.876998,"eighty":-1.28764,"marketCap":87718013},{"date":"2025-05-02","current":-1.150507,"twenty":-3.328025,"median":-1.867273,"eighty":-1.252628,"marketCap":85018997},{"date":"2025-05-09","current":-1.088206,"twenty":-3.166583,"median":-1.847822,"eighty":-1.218825,"marketCap":80415162},{"date":"2025-05-16","current":-0.872124,"twenty":-3.152968,"median":-1.818646,"eighty":-1.187031,"marketCap":81090920},{"date":"2025-05-23","current":-0.872124,"twenty":-3.141297,"median":-1.818646,"eighty":-1.164325,"marketCap":81090920},{"date":"2025-05-30","current":-0.886659,"twenty":-3.134489,"median":-1.784607,"eighty":-1.159638,"marketCap":82442435},{"date":"2025-06-06","current":-0.901194,"twenty":-3.10434,"median":-1.750568,"eighty":-1.150507,"marketCap":83793951},{"date":"2025-06-13","current":-0.930265,"twenty":-3.086835,"median":-1.590099,"eighty":-1.125277,"marketCap":86496981},{"date":"2025-06-20","current":-0.893927,"twenty":-3.063494,"median":-1.522022,"eighty":-1.106495,"marketCap":83118193},{"date":"2025-06-27","current":-0.91573,"twenty":-3.014867,"median":-1.478258,"eighty":-1.095721,"marketCap":85145466},{"date":"2025-07-03","current":-0.930265,"twenty":-3.007087,"median":-1.439356,"eighty":-1.066502,"marketCap":86496981},{"date":"2025-07-11","current":-0.981139,"twenty":-2.997362,"median":-1.429631,"eighty":-1.007303,"marketCap":91227285},{"date":"2025-07-18","current":-1.061084,"twenty":-2.995417,"median":-1.400454,"eighty":-0.995674,"marketCap":98660619},{"date":"2025-07-25","current":-1.075619,"twenty":-2.995417,"median":-1.376141,"eighty":-1.007303,"marketCap":100012135},{"date":"2025-08-01","current":-1.017477,"twenty":-2.979856,"median":-1.361553,"eighty":-1.016024,"marketCap":94606073},{"date":"2025-08-08","current":-1.220973,"twenty":-2.968185,"median":-1.346965,"eighty":-1.017477,"marketCap":113527288},{"date":"2025-08-15","current":-2.492713,"twenty":-2.95846,"median":-1.351828,"eighty":-1.023291,"marketCap":116554252},{"date":"2025-08-22","current":-3.173861,"twenty":-2.979856,"median":-1.366416,"eighty":-1.024745,"marketCap":148403379},{"date":"2025-08-29","current":-3.333278,"twenty":-3.007087,"median":-1.381004,"eighty":-1.030392,"marketCap":155857430},{"date":"2025-09-05","current":-3.376756,"twenty":-3.075164,"median":-1.400454,"eighty":-1.031929,"marketCap":157890353},{"date":"2025-09-12","current":-3.478204,"twenty":-3.149077,"median":-1.429631,"eighty":-1.042845,"marketCap":162633840},{"date":"2025-09-19","current":-3.246323,"twenty":-3.164638,"median":-1.439356,"eighty":-1.052316,"marketCap":151791584},{"date":"2025-09-26","current":-3.043428,"twenty":-3.197049,"median":-1.483121,"eighty":-1.053816,"marketCap":142304610},{"date":"2025-10-03","current":-2.956473,"twenty":-3.173861,"median":-1.53661,"eighty":-1.057045,"marketCap":138238764},{"date":"2025-10-10","current":-2.739085,"twenty":-3.171828,"median":-1.667902,"eighty":-1.060329,"marketCap":128074149},{"date":"2025-10-17","current":-2.82604,"twenty":-3.164638,"median":-1.760293,"eighty":-1.06543,"marketCap":132139995},{"date":"2025-10-24","current":-2.88401,"twenty":-3.171828,"median":-1.808921,"eighty":-1.072703,"marketCap":134850559},{"date":"2025-10-31","current":-2.88401,"twenty":-3.164638,"median":-1.818646,"eighty":-1.075619,"marketCap":134850559},{"date":"2025-11-07","current":-2.603692,"twenty":-3.149077,"median":-1.838097,"eighty":-1.083171,"marketCap":132139995},{"date":"2025-11-14","current":-2.512362,"twenty":-3.141297,"median":-1.857547,"eighty":-1.088206,"marketCap":127504893},{"date":"2025-11-21","current":-2.324271,"twenty":-3.120874,"median":-1.876998,"eighty":-1.092715,"marketCap":117959072},{"date":"2025-11-28","current":-2.539232,"twenty":-3.101423,"median":-1.886723,"eighty":-1.096373,"marketCap":128868582},{"date":"2025-12-05","current":-2.324271,"twenty":-3.090364,"median":-1.896449,"eighty":-1.097379,"marketCap":117959072},{"date":"2025-12-12","current":-3.090071,"twenty":-3.088805,"median":-1.930487,"eighty":-1.097422,"marketCap":156824200},{"date":"2025-12-19","current":-5.88457,"twenty":-3.141297,"median":-1.945076,"eighty":-1.098568,"marketCap":298647825},{"date":"2025-12-26","current":-4.562679,"twenty":-3.173183,"median":-1.969389,"eighty":-1.101167,"marketCap":231560509},{"date":"2026-01-02","current":-3.763034,"twenty":-3.231831,"median":-2.032604,"eighty":-1.10469,"marketCap":190977740},{"date":"2026-01-09","current":-4.308674,"twenty":-3.260816,"median":-2.195782,"eighty":-1.104852,"marketCap":218669512},{"date":"2026-01-16","current":-3.54666,"twenty":-3.333278,"median":-2.236837,"eighty":-1.106495,"marketCap":179996519},{"date":"2026-01-23","current":-4.619124,"twenty":-3.365162,"median":-2.283966,"eighty":-1.112485,"marketCap":234425175},{"date":"2026-01-30","current":-4.496826,"twenty":-3.449218,"median":-2.324271,"eighty":-1.121288,"marketCap":228218399},{"date":"2026-02-06","current":-4.374527,"twenty":-3.488132,"median":-2.337706,"eighty":-1.123114,"marketCap":222011622},{"date":"2026-02-13","current":-4.957797,"twenty":-3.580579,"median":-2.363428,"eighty":-1.131766,"marketCap":251613172},{"date":"2026-02-20","current":-5.305878,"twenty":-3.670837,"median":-2.397337,"eighty":-1.138397,"marketCap":269278613},{"date":"2026-02-27","current":-6.942798,"twenty":-3.770448,"median":-2.418317,"eighty":-1.146855,"marketCap":352353930},{"date":"2026-03-06","current":-5.895163,"twenty":-3.911674,"median":-2.457761,"eighty":-1.150507,"marketCap":352831374},{"date":"2026-03-13","current":-5.794315,"twenty":-4.006508,"median":-2.512362,"eighty":-1.150507,"marketCap":346795534},{"date":"2026-03-20","current":-5.570843,"twenty":-4.127762,"median":-2.533915,"eighty":-1.150507,"marketCap":333420500},{"date":"2026-03-27","current":-5.674598,"twenty":-4.262099,"median":-2.552667,"eighty":-1.150507,"marketCap":339630337},{"date":"2026-04-02","current":-5.546899,"twenty":-4.40275,"median":-2.552667,"eighty":-1.154159,"marketCap":331987461},{"date":"2026-04-10","current":-6.424826,"twenty":-4.493063,"median":-2.591615,"eighty":-1.159638,"marketCap":384532239},{"date":"2026-04-17","current":-7.039457,"twenty":-4.68874,"median":-2.608653,"eighty":-1.159638,"marketCap":421318549},{"date":"2026-04-24","current":-7.199082,"twenty":-4.833617,"median":-2.724593,"eighty":-1.160328,"marketCap":430872257},{"date":"2026-05-01","current":-7.087345,"twenty":-4.902724,"median":-2.742557,"eighty":-1.16195,"marketCap":424184661},{"date":"2026-05-08","current":-9.505662,"twenty":-5.051841,"median":-2.788531,"eighty":-1.165206,"marketCap":568923347},{"date":"2026-05-15","current":-10.251886,"twenty":-5.174172,"median":-2.811548,"eighty":-1.168769,"marketCap":541217592},{"date":"2026-05-22","current":-9.871852,"twenty":-5.232411,"median":-2.842555,"eighty":-1.168769,"marketCap":521154804},{"date":"2026-05-29","current":-10.260935,"twenty":-5.270935,"median":-2.876764,"eighty":-1.172421,"marketCap":541695277},{"date":"2026-06-05","current":-9.871852,"twenty":-5.327624,"median":-2.88401,"eighty":-1.187031,"marketCap":521154804},{"date":"2026-06-12","current":-9.871852,"twenty":-5.377318,"median":-2.898503,"eighty":-1.187031,"marketCap":521154804},{"date":"2026-06-18","current":-12.299862,"twenty":-5.428177,"median":-2.912995,"eighty":-1.187031,"marketCap":649334330},{"date":"2026-06-26","current":-13.731592,"twenty":-5.484622,"median":-2.927339,"eighty":-1.196162,"marketCap":724918221},{"date":"2026-07-02","current":-14.414918,"twenty":-5.570843,"median":-2.937064,"eighty":-1.198568,"marketCap":760992350},{"date":"2026-07-10","current":-14.989779,"twenty":-5.662848,"median":-2.956494,"eighty":-1.212372,"marketCap":791340427},{"date":"2026-07-17","current":-13.644821,"twenty":-5.682623,"median":-2.970966,"eighty":-1.219913,"marketCap":720337379},{"date":"2026-07-24","current":-13.840057,"twenty":-5.734417,"median":-2.990438,"eighty":-1.223039,"marketCap":730644273},{"date":"2026-07-31","current":-13.102499,"twenty":-5.816662,"median":-2.995417,"eighty":-1.223555,"marketCap":691707117},{"date":"2026-08-07","current":-13.912299,"twenty":-5.930387,"median":-3.014443,"eighty":-1.230727,"marketCap":801682322},{"date":"2026-08-14","current":-14.682008,"twenty":-6.54289,"median":-3.029148,"eighty":-1.235508,"marketCap":846036036},{"date":"2026-08-21","current":-16.964547,"twenty":-6.686846,"median":-3.057921,"eighty":-1.239293,"marketCap":977565060},{"date":"2026-08-25","current":-16.346567,"twenty":-6.726423,"median":-3.063494,"eighty":-1.241817,"marketCap":941954582}],"updateTime":1787734710333},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLYM\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633692800","title":"Climb Bio Initiated at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2633692800","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633692800?lang=en_us&edition=fundamental","pubTime":"2026-05-06 03:06","pubTimestamp":1778007960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 15:06 ET (19:06 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914019","title":"Climb Bio reports Phase 1 budoprutug subcutaneous data supports patient trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914019","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914019?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:08","pubTimestamp":1777979296,"startTime":"0","endTime":"0","summary":"Climb Bio disclosed topline Phase 1 results showing budoprutug subcutaneous dosing produced B-cell depletion comparable to intravenous administration in healthy volunteers, supporting continued development.Safety profile was described as generally acceptable, backing plans to move subcutaneous dosing into autoimmune disease patients.Clinical trials in primary membranous nephropathy, immune thrombocytopenia, systemic lupus erythematosus remain on track, with first ITP data expected in June.Initial readouts from pMN and SLE studies are slated for Q4 2026, setting up multiple clinical catalysts tied to dosing strategy and broader expansion across B-cell mediated diseases.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL37yPN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4112","BK4539","NDAQ","LU2095319765.USD","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4585","SG9999014013.SGD","LU2210149790.SGD","BK4588","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","CLYM","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633911838","title":"Chardan Initiates Climb Bio at Buy With $22 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2633911838","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633911838?lang=en_us&edition=fundamental","pubTime":"2026-05-05 18:44","pubTimestamp":1777977892,"startTime":"0","endTime":"0","summary":"Climb Bio (CLYM) has an average rating of buy and mean price target of $16.69, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633992044","title":"U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi","url":"https://stock-news.laohu8.com/highlight/detail?id=2633992044","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633992044?lang=en_us&edition=fundamental","pubTime":"2026-05-05 15:07","pubTimestamp":1777964820,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, OnsemiMay 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL4N41I0F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESPR","GBTG","RYAN","CRWG","PLTR","H","ACMR","AMAT","DDOG","BR","MZTI","CONX","EVER","RBA","AEIS","DUOL","AXSM","LSCC","WGS","ICHR","CNO","PLTU","KNSL","NCLH","CRCL","ICOI","DT","PLTY","CLYM","GPI","CORD","INSP","COIW","PLOO","APD","ARE","PINS","CRWV","HUBB","PLTW","CBRE","LRCX","RBLX","TGT","COIN","DOGD","CVX","FLGT","CHD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633993177","title":"Climb Bio Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $22","url":"https://stock-news.laohu8.com/highlight/detail?id=2633993177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633993177?lang=en_us&edition=fundamental","pubTime":"2026-05-05 10:43","pubTimestamp":1777949013,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41H0RB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632307969","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Climb Bio (CLYM), ICU Medical (ICUI) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632307969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632307969?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:41","pubTimestamp":1777894897,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Climb Bio (CLYM), ICU Medical (ICUI) and Stryker (SYK). Climb Bio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-climb-bio-clym-icu-medical-icui-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-climb-bio-clym-icu-medical-icui-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0012050646.USD","GB00B4QBRK32.GBP","LU0882574055.USD","LU1791710400.SGD","XBI","BK4566","SG9999015952.SGD","CLYM","SG9999015986.USD","LU0690374961.EUR","LU0289739699.SGD","LU0029874061.USD","SG9999015945.SGD","LU2404859667.USD","BK4082","HCSG","LU2362540622.SGD","LU2362541273.HKD","SYK","LU0823417653.USD","LU0950375773.USD","LU0240877869.USD","LU2506951875.HKD","ICUI","BK4137","BK4585","LU0205194284.USD","LU2506952170.USD","LU2089984988.USD","BK4139","LU0432979614.USD","LU2506952097.USD","LU2324357040.USD","GB00B4LPDJ14.GBP","BK4504","LU0114720955.EUR","ICU","XLV","LU2362541513.USD","LU0106261612.USD","LU0240878834.USD","LU1983299246.USD","SG9999015978.USD","BK4198","LU2468319806.SGD","LU1791710582.SGD","LU2506951958.HKD","LU0690374615.EUR","LU0528227936.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632193071","title":"Piper Sandler Remains a Buy on Climb Bio (CLYM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632193071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632193071?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:40","pubTimestamp":1777894814,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Climb Bio, with a price target of $23.00. Rahimi covers th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630758913","title":"BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics","url":"https://stock-news.laohu8.com/highlight/detail?id=2630758913","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630758913?lang=en_us&edition=fundamental","pubTime":"2026-04-28 23:39","pubTimestamp":1777390791,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, VeradermicsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nL6N41B15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMUU","ZBH","UGI","XOMO","MUU","MU","AXGN","CVX","GM","XOMZ","KO","SNVD.UK","ARM","NEM","DT","ORCU","DPZ","XOMX","ANV","SBU","NVDS.UK","NVDA","RMBS","GLW","SHW","MANE","UPS","AMD","OXY","UHS","JBLU","HLT","MUD","SFD","ALLE","BBBY","ORCL","ERAS","AMGN","KMB","SANM","LFST","EPD","NVD2.UK","APA","CNC","SPOT","CLYM","SBUX","XOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630303403","title":"Climb Bio prices USD 110 million private placement at USD 9.5 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2630303403","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630303403?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:05","pubTimestamp":1777374338,"startTime":"0","endTime":"0","summary":"Climb Bio priced a private placement expected to raise about USD 110 million in gross proceeds.Deal includes sale of 9,481,000 common shares at USD 9.5 per share.Offering also includes pre-funded warrants for up to 2,106,000 shares at USD 9.5 per warrant, with a USD 0.0001 exercise price.Closing is expected on or about April 29, 2026.Company plans to file a resale registration statement with SEC within 45 days of closing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLvhFY2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4588","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4112","BK4139","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","BK4539","BK4585","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630303630","title":"Climb Bio Inc - Private Placement Expected to Close on or About April 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2630303630","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630303630?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:00","pubTimestamp":1777374000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUA8DP12P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630303904","title":"Press Release: Climb Bio, Inc. Announces $110.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2630303904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630303904?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:00","pubTimestamp":1777374000,"startTime":"0","endTime":"0","summary":"WELLESLEY HILLS, Mass., April 28, 2026  -- Climb Bio, Inc. , a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors to sell securities in a private placement for aggregate gross proceeds of approximately $110.0 million, before deducting placement agent fees and other offering expenses. The private placement is expected to close on or about April 29, 2026, subject to the satisfaction of customary closing conditions.Leerink Partners and Piper Sandler are acting as lead placement agents in the private placement. Raymond James, BTIG, Baird, and H.C. Wainwright & Co. are also acting as placement agents in the private placement.This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdict","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630827350","title":"Climb Bio announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630827350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630827350?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:20","pubTimestamp":1777062002,"startTime":"0","endTime":"0","summary":"Climb Bio scheduled 2026 annual stockholders meeting for June 5, 2026, to be held virtually via Internet.Shareholders will vote on election of two Class II directors: Alexander  Cumbo, Douglas Williams.Investors will consider amendment to certificate of incorporation on removal of directors for “cause”.Meeting will also vote on amendment to 2021 Equity Incentive Plan to include prefunded warrants in automatic annual share pool increase calculation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL5YxYcj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629039921","title":"Analysts Offer Insights on Healthcare Companies: Passage Bio (PASG), Climb Bio (CLYM) and Zai Lab (ZLAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629039921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629039921?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:20","pubTimestamp":1776774032,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Passage Bio (PASG), Climb Bio (CLYM) and Zai Lab (ZL...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-passage-bio-pasg-climb-bio-clym-and-zai-lab-zlab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-passage-bio-pasg-climb-bio-clym-and-zai-lab-zlab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4531","ZLAB","BK4137","LABU","BK4539","BK4526","XBI","BK4581","BK4548","XLV","BK4585","LU0128526141.USD","HCSG","PASG","BK4139","BK4588","LU0029874061.USD","CLYM","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629208501","title":"U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis","url":"https://stock-news.laohu8.com/highlight/detail?id=2629208501","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629208501?lang=en_us&edition=fundamental","pubTime":"2026-04-21 16:08","pubTimestamp":1776758891,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis April 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CNX Resource","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nL4N4140LG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEX","CHH","BEG","AAOX","APD","BE","AR","AMP","BKNG","ANET","CAKE","AAMI","CVNA","CLF","AWK","ATO","CCBG","BEZ","CLYM","CMS","COHR","LABX","RCUS","AAOI","AGIO","CNX","CPK","CVNX","BSX","ALB","AEE","ALLY","CHMG","ALBG","AEP","AMBQ","CCNE","BOH","CAR","CVNY","CZR","CNP","ABT","ALAB","ADC","PG","ARWR","CE","BKNU","BWA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627889404","title":"Climb Bio Inc : Mizuho Initiates Coverage With Outperform Rating; Price Target $18","url":"https://stock-news.laohu8.com/highlight/detail?id=2627889404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627889404?lang=en_us&edition=fundamental","pubTime":"2026-04-15 16:05","pubTimestamp":1776240334,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y03L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626411028","title":"Climb Bio announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2626411028","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626411028?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:07","pubTimestamp":1775851646,"startTime":"0","endTime":"0","summary":"Climb Bio schedules 2026 annual stockholder meeting for June 5, 2026, to be held virtually via Internet.Meeting agenda includes election of two Class II directors: Alexander  Cumbo, Douglas Williams.Ballot includes amendment to certificate of incorporation covering removal of directors for cause.Vote also set on amendment to 2021 equity incentive plan to include prefunded warrants in annual automatic share pool increase calculation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL1BM3xN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626194162","title":"Climb Bio (CLYM) Gets a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2626194162","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626194162?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:17","pubTimestamp":1775819860,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Climb Bio today and set a price target of $23.00. According to TipRanks, Rahimi is ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/climb-bio-clym-gets-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/climb-bio-clym-gets-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625044948","title":"Climb Bio hosts R&D Spotlight webcast on budoprutug CD19 program opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2625044948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625044948?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:00","pubTimestamp":1775646049,"startTime":"0","endTime":"0","summary":"Climb Bio will host an R&D Spotlight webcast on budoprutug on May 5, 2026, at 8:00 a.m. ET.Session will outline development strategy for budoprutug, anti-CD19 antibody in trials for primary membranous nephropathy, immune thrombocytopenia, systemic lupus erythematosus.David Jayne, University of Cambridge, will join management as guest speaker.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLy67DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4539","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014039.USD","BK4588","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4139","SG9999014021.USD","CLYM","BK4112","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625912269","title":"Climb Bio Price Target Maintained With a $8.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2625912269","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625912269?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:49","pubTimestamp":1775641740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2026 05:49 ET (09:49 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625932666","title":"Climb Bio says FDA grants Fast Track designation for budoprutug in pMN","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932666","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625932666?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:04","pubTimestamp":1775559884,"startTime":"0","endTime":"0","summary":"Climb Bio received FDA Fast Track designation for budoprutug in primary membranous nephropathy.Decision supports accelerated development pathway for investigational anti-CD19 antibody in rare kidney disease with no FDA-approved treatments.Phase 2 open-label PrisMN trial remains enrolling, with initial data expected in H2 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL7jRVM6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":105,"code":"91000000","status":"200"}]}}